Evaluating Match Rates Between OASIS Assessments and Medicare Claims Data
April 4, 2026
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
N/A
Synonyms :
vonifimod
Class :
Chemical immunomodulator
Brand Name :
N/A
Synonyms :
vonifimod
Class :
Chemical immunomodulator
Dosage Forms & Strengths
It is being investigated for inflammatory and autoimmune diseases
It is an investigational drug that is being developed for the treatment of autoimmune and inflammatory diseases
Not determined
Refer to adult dosing
Actions and Spectrum
Vonifimod is a selective modulator of sphingosine-1-phosphate receptor1, which plays a role in immune response regulation.
Frequency not defined
None
Black Box Warning
None
Contraindication/Caution:
None
Pregnancy/Lactation
Pregnancy consideration:
Pregnancy category: N/A
Lactation: Excretion into human milk is unknown
Pregnancy Categories:
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.
Category B: There were a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments
Category C: There was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: Adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology
Vonifimond is immune cell modulator for lymphocytes. Modulation of these receptors may alter the movement of immune cells and provide anti- inflammatory effect.
Pharmacodynamics
Vonifimod may influence the migration and circulation of immune cells, impacting their distribution and function in different tissues.
Pharmacokinetics
Limited information available on ADME.
Administration
The administration of vonifimod is not known.
Patient information leaflet
Generic Name: vonifimod
Why do we use vonifimod?
Vonifimod is an immunomodulator and is being researched for its potential therapeutic applications.
Vonifimod is under investigation which is developed for the treatment of autoimmune diseases.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
